Then, the secretory leukocyte protease inhibitor protein(SLPI) is known to regulate the penetrance of frontotemporal lobar degeneration (FTLD) in patients who have mutations in the progranulin gene (Ghidoni et al., 2014). This evidence concerns the gene GRN and frontotemporal dementia.